Ismail M, Swierzy M, Ulrich M, Rückert J C
Klinik für Allgemein-, Visceral-, Gefäß- und Thoraxchirurgie, Charité - Universitätsmedizin Berlin, Campus Charité Mitte, Charitéplatz 1, 10117, Berlin, Deutschland.
Chirurg. 2013 Aug;84(8):643-50. doi: 10.1007/s00104-013-2502-3.
The latest technical developments of minimally invasive thoracic surgery are characterized by robotic-assisted operative procedures. Robotic-assisted thymectomy is the most advanced method in this field.
A systematic literature search (PubMed, Medline) was carried out and the databank system of Intuitive Surgical (Sunnyvale, CA) was analysed. Target criteria were the analysis of the quantitative data over time, technical advantages and limiting factors of robotic-assisted thoracic surgery.
The da Vinci robotic system has been used in thoracic surgery since 2001, and up to 2012 a total of 10,895 robotic-assisted lobotomies have been carried out worldwide. A total of 12 ectopic parathyroid glands in the mediastinum were resected and published. Furthermore, more than 3,500 cases of robotic-assisted thymectomy were performed. A rapid increase in the number of operations has occurred particularly for thymectomy and lung resections.
Acceptance of robotic-assisted thymectomy for myasthenia and/or thymoma and mediastinal tumors is growing rapidly. For anatomic lung resection in lung cancer, robotic-assisted hilar and lymph node dissection due to this new quality are also comparable to open surgical techniques. The principles form the intrinsic technical advantages of the da Vinci robotic system.
微创胸外科的最新技术发展以机器人辅助手术为特征。机器人辅助胸腺切除术是该领域最先进的方法。
进行了系统的文献检索（PubMed、Medline），并分析了直观外科公司（加利福尼亚州森尼韦尔市）的数据库系统。目标标准是分析机器人辅助胸外科手术随时间的定量数据、技术优势和限制因素。
达芬奇机器人系统自2001年起用于胸外科手术，截至2012年，全球共进行了10895例机器人辅助肺叶切除术。共切除并发表了纵隔内12个异位甲状旁腺。此外，还进行了3500多例机器人辅助胸腺切除术。手术数量尤其在胸腺切除术和肺切除术中迅速增加。
机器人辅助胸腺切除术治疗重症肌无力和/或胸腺瘤及纵隔肿瘤的接受度正在迅速提高。对于肺癌中的解剖性肺切除术，由于这种新特性，机器人辅助肺门和淋巴结清扫术也与开放手术技术相当。这些原则构成了达芬奇机器人系统的内在技术优势。
Zotero 插件